Archive - March 2018
Sarepta looks to get 2nd experimental Duchenne drug approved
Study: Common gout drug raises risk of death
Sanofi, Regeneron offer price cut for cholesterol drug Praluent
Hikma/Vectura’s generic Advair delayed in the US
AZ pushes back data read-out from MYSTIC lung cancer trial
CDM develops creative global collaboration model
Sanofi, Regeneron to cut price of Praluent
AZ announces results delay for key lung cancer trial